ABSTRACT
BACKGROUND: For patients to effectively manage gout, they need to be aware of the impact of diet, alcohol use, and medications on their condition. We sought to examine patients' knowledge and beliefs concerning gout and its treatment in order to identify barriers to optimal patient self-management. METHODS: We identified patients (≥18 years of age) cared for in the setting of a multispecialty group practice with documentation of at least one health care encounter associated with a gout diagnosis during the period 2008-2009 (n = 1346). Patients were sent a questionnaire assessing knowledge with regard to gout, beliefs about prescription medications used to treat gout, and trust in the physician. Administrative electronic health records were used to identify prescription drug use and health care utilization. RESULTS: Two hundred and forty patients returned surveys out of the 500 contacted for participation. Most were male (80%), white (94%), and aged 65 and older (66%). Only 14 (6%) patients were treated by a rheumatologist. Only a minority of patients were aware of common foods known to trigger gout (e.g., seafood [23%], beef [22%], pork [7%], and beer [43%]). Of those receiving a urate-lowering medication, only 12% were aware of the short-term risks of worsening gout with initiation. These deficits were more common in those with active as compared to inactive gout. CONCLUSION: Knowledge deficits about dietary triggers and chronic medications were common, but worse in those with active gout. More attention is needed on patient education on gout and self-management training.
Subject(s)
Culture , Gout Suppressants/therapeutic use , Gout/therapy , Health Knowledge, Attitudes, Practice , Population Surveillance/methods , Self Care/methods , Aged , Alcohol Drinking/adverse effects , Alcohol Drinking/epidemiology , Diet/adverse effects , Female , Gout/epidemiology , Gout/psychology , Gout Suppressants/adverse effects , Humans , Male , Meat/adverse effects , Middle Aged , Seafood/adverse effects , Surveys and Questionnaires , Treatment OutcomeABSTRACT
BACKGROUND: Patients with normal (mean pulmonary arterial pressure (mPAP) ≤20 mm Hg) and borderline mean pulmonary pressures (21-24 mm Hg) are "at risk" of developing pulmonary hypertension (PH). The objectives of this analysis were to examine the baseline characteristics in systemic sclerosis (SSc) with normal and borderline mPAP and to explore long-term outcomes in SSc patients with borderline mPAP versus normal haemodynamics. METHODS: PHAROS is a multicentre prospective longitudinal cohort of patients with SSc "at risk" or recently diagnosed with resting PH on right heart catheterisation (RHC). Baseline clinical characteristics, pulmonary function tests, high-resolution CT, 2-dimensional echocardiogram and RHC results were analysed in normal and borderline mPAP groups. RESULTS: 206 patients underwent RHC (results showed 35 normal, 28 borderline mPAP, 143 resting PH). There were no differences in the baseline demographics. Patients in the borderline mPAP group were more likely to have restrictive lung disease (67% vs 30%), fibrosis on high-resolution CT and a higher estimated right ventricular systolic pressure on echocardiogram (46.3 vs 36.2 mm Hg; p<0.05) than patients with normal haemodynamics. RHC revealed higher pulmonary vascular resistance and more elevated mPAP on exercise (≥30; 88% vs 56%) in the borderline mPAP group (p<0.05 for both). Patients were followed for a mean of 25.7 months and 24 patients had a repeat RHC during this period. During follow-up, 55% of the borderline mPAP group and 32% of the normal group developed resting PH (p=NS). CONCLUSIONS: Patients with borderline mPAP have a greater prevalence of abnormal lung physiology, pulmonary fibrosis and the presence of exercise mPAP ≥30 mm Hg.
Subject(s)
Blood Pressure/physiology , Hypertension, Pulmonary/physiopathology , Pulmonary Artery/physiopathology , Scleroderma, Systemic/physiopathology , Cardiac Catheterization , Female , Follow-Up Studies , Hemodynamics , Humans , Hypertension, Pulmonary/complications , Hypertension, Pulmonary/diagnosis , Male , Middle Aged , Prospective Studies , Pulmonary Fibrosis/complications , Pulmonary Fibrosis/physiopathology , Respiratory Function Tests , Scleroderma, Systemic/complications , Scleroderma, Systemic/diagnosisABSTRACT
As multi-detector-row computed tomography (CT) technology evolves, manifold applications of CT scanning have been adopted in clinical practice and optimization of scanning protocols to comply with an "as low as reasonably achievable" radiation dose have become more complex. Automatic exposure control techniques, which have been recently introduced on most state-of-the-art CT equipment, aid in radiation dose optimization at a selected image quality. The present article reviews the fundamentals of automatic exposure control techniques in CT, along with the scanning protocols and associated radiation dose reduction.